Scientists grow 'Mini-Guts' to solve drug mystery for sick kids

NCT ID NCT07400783

Summary

This study aims to understand why children with short bowel syndrome (SBS) respond differently to a drug called teduglutide. Researchers will grow tiny, lab-made versions of a patient's intestine (organoids) from tissue samples taken during their standard surgeries. By testing the drug on these 'mini-intestines' in the lab, they hope to learn what makes some patients benefit more than others, which could lead to better, personalized treatments in the future.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME (SBS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aou Meyer IRCSS

    RECRUITING

    Florence, Florence, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.